Sakar Healthcare Limited (SAKAR.NS)
INR 239.9
(1.64%)
INR 239.9
(1.64%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 3.88 Billion INR | 15.56% |
| 2022 | 3.36 Billion INR | 25.61% |
| 2021 | 2.67 Billion INR | 50.61% |
| 2020 | 1.77 Billion INR | 54.44% |
| 2019 | 1.15 Billion INR | 16.66% |
| 2018 | 986.84 Million INR | 21.68% |
| 2017 | 810.99 Million INR | 14.89% |
| 2016 | 705.87 Million INR | 38.11% |
| 2015 | 511.09 Million INR | 1.86% |
| 2014 | 501.75 Million INR | -4.13% |
| 2013 | 523.36 Million INR | 4.48% |
| 2012 | 500.93 Million INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2024 Q2 | 4.04 Billion INR | 0.0% |
| 2023 FY | 3.95 Billion INR | 17.5% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q4 | 3.88 Billion INR | 0.0% |
| 2023 Q2 | 3.57 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2022 Q2 | 2.97 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 3.36 Billion INR | 25.61% |
| 2022 Q4 | 3.36 Billion INR | 0.0% |
| 2021 FY | 2.67 Billion INR | 50.61% |
| 2021 Q4 | 2.67 Billion INR | 0.0% |
| 2021 Q2 | 2.25 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2020 FY | 1.77 Billion INR | 54.44% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q4 | 1.77 Billion INR | 0.0% |
| 2020 Q2 | 1.47 Billion INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2019 Q4 | 1.15 Billion INR | 0.0% |
| 2019 FY | 1.15 Billion INR | 16.66% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q2 | 1.06 Billion INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 Q2 | 902.88 Million INR | 0.0% |
| 2018 Q4 | 986.84 Million INR | 0.0% |
| 2018 FY | 986.84 Million INR | 21.68% |
| 2017 FY | 810.99 Million INR | 14.89% |
| 2017 Q4 | 810.99 Million INR | 0.0% |
| 2017 Q2 | 750.63 Million INR | 0.0% |
| 2016 Q4 | 705.87 Million INR | 0.0% |
| 2016 FY | 705.87 Million INR | 38.11% |
| 2015 Q1 | 531.11 Million INR | 5.85% |
| 2015 Q4 | 511.09 Million INR | 0.0% |
| 2015 Q2 | 531.11 Million INR | 0.0% |
| 2015 FY | 511.09 Million INR | 1.86% |
| 2015 Q3 | 511.09 Million INR | -3.77% |
| 2014 FY | 501.75 Million INR | -4.13% |
| 2014 Q4 | 501.75 Million INR | 0.0% |
| 2013 FY | 523.36 Million INR | 4.48% |
| 2012 FY | 500.93 Million INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Aarti Drugs Limited | 24.32 Billion INR | 84.021% |
| Aarti Pharmalabs Limited | 25.82 Billion INR | 84.948% |
| Albert David Limited | 4.97 Billion INR | 21.955% |
| Alembic Limited | 23.28 Billion INR | 83.311% |
| Biofil Chemicals and Pharmaceuticals Limited | 470.82 Million INR | -725.482% |
| Hester Biosciences Limited | 6.62 Billion INR | 41.321% |
| Hikal Limited | 24.87 Billion INR | 84.373% |
| Ind-Swift Laboratories Limited | 11.65 Billion INR | 66.642% |
| Ind-Swift Limited | 6.54 Billion INR | 40.615% |
| IOL Chemicals and Pharmaceuticals Limited | 22.44 Billion INR | 82.683% |
| Kilitch Drugs (India) Limited | 2.4 Billion INR | -61.9% |
| Lincoln Pharmaceuticals Limited | 7 Billion INR | 44.5% |
| Mangalam Drugs & Organics Limited | 3.33 Billion INR | -16.566% |
| Medico Remedies Limited | 961.95 Million INR | -304.031% |
| Morepen Laboratories Limited | 12.93 Billion INR | 69.946% |
| Procter & Gamble Health Limited | 7.94 Billion INR | 51.073% |
| RPG Life Sciences Limited | 5.12 Billion INR | 24.219% |
| Sigachi Industries Limited | 6.94 Billion INR | 44.01% |
| Sun Pharmaceutical Industries Limited | 854.62 Billion INR | 99.545% |
| Suven Pharmaceuticals Limited | 22.54 Billion INR | 82.758% |
| Themis Medicare Limited | 5.66 Billion INR | 31.383% |
| Unichem Laboratories Limited | 31.69 Billion INR | 87.737% |
| Vaishali Pharma Limited | 799.55 Million INR | -386.093% |
| Venus Remedies Limited | 6.26 Billion INR | 37.996% |
| Windlas Biotech Limited | 6.26 Billion INR | 37.934% |
| ZIM Laboratories Limited | 4.46 Billion INR | 13.017% |
| Alembic Pharmaceuticals Limited | 64.45 Billion INR | 93.97% |
| Bafna Pharmaceuticals Limited | 1.47 Billion INR | -163.174% |
| FDC Limited | 24.68 Billion INR | 84.253% |
| Gufic Biosciences Limited | 10.92 Billion INR | 64.426% |
| Jubilant Pharmova Limited | 115.48 Billion INR | 96.635% |
| Nectar Lifesciences Limited | 21.91 Billion INR | 82.262% |
| Orchid Pharma Limited | 15.53 Billion INR | 74.988% |
| Alkem Laboratories Limited | 155.74 Billion INR | 97.505% |
| Bajaj HealthCare Limited | 7.65 Billion INR | 49.203% |
| Brooks Laboratories Limited | 904.45 Million INR | -329.717% |
| Eris Lifesciences Limited | 70.48 Billion INR | 94.486% |
| Glenmark Life Sciences Limited | 28.5 Billion INR | 86.365% |
| Solara Active Pharma Sciences Limited | 23.46 Billion INR | 83.437% |
| Innova Captab Limited | 13.2 Billion INR | 70.576% |
| Jagsonpal Pharmaceuticals Limited | 2.17 Billion INR | -79.041% |
| Wanbury Limited | 3.43 Billion INR | -13.149% |
| Lupin Limited | 239.97 Billion INR | 98.38% |
| Aurobindo Pharma Limited | 450.71 Billion INR | 99.138% |
| Divi's Laboratories Limited | 154.7 Billion INR | 97.488% |
| AstraZeneca Pharma India Limited | 10.78 Billion INR | 63.947% |
| Mankind Pharma Limited | 119.63 Billion INR | 96.751% |
| Sequent Scientific Limited | 15.4 Billion INR | 74.769% |
| Laurus Labs Limited | 83.87 Billion INR | 95.366% |
| Neuland Laboratories Limited | 18.32 Billion INR | 78.791% |
| J. B. Chemicals & Pharmaceuticals Limited | 39.94 Billion INR | 90.269% |
| Glenmark Pharmaceuticals Limited | 143.58 Billion INR | 97.293% |
| Zydus Lifesciences Limited | 292.8 Billion INR | 98.673% |
| Amrutanjan Health Care Limited | 3.66 Billion INR | -5.939% |
| Wockhardt Limited | 76.49 Billion INR | 94.919% |
| Bal Pharma Limited | 3.2 Billion INR | -21.309% |
| Dr. Reddy's Laboratories Limited | 387.51 Billion INR | 98.997% |
| Bliss GVS Pharma Limited | 12.13 Billion INR | 67.982% |
| Par Drugs and Chemicals Limited | 1.01 Billion INR | -282.497% |
| Caplin Point Laboratories Limited | 26.97 Billion INR | 85.591% |
| Shilpa Medicare Limited | 30.93 Billion INR | 87.435% |
| Valiant Laboratories Limited | 3.42 Billion INR | -13.415% |
| Ajanta Pharma Limited | 46.38 Billion INR | 91.621% |
| Aarey Drugs & Pharmaceuticals Limited | 3.04 Billion INR | -27.433% |
| Granules India Limited | 55.2 Billion INR | 92.96% |
| Medicamen Biotech Limited | 2.94 Billion INR | -31.962% |
| Ipca Laboratories Limited | 111.01 Billion INR | 96.499% |
| Syncom Formulations (India) Limited | 4.04 Billion INR | 3.955% |
| Piramal Enterprises Limited | 826.05 Billion INR | 99.529% |
| Torrent Pharmaceuticals Limited | 150.61 Billion INR | 97.419% |
| NATCO Pharma Limited | 69.06 Billion INR | 94.372% |
| Suven Life Sciences Limited | 2.84 Billion INR | -36.418% |
| Krebs Biochemicals & Industries Limited | 1.78 Billion INR | -118.134% |
| Strides Pharma Science Limited | 58.39 Billion INR | 93.345% |
| Indoco Remedies Limited | 21.44 Billion INR | 81.878% |
| Alpa Laboratories Limited | 1.82 Billion INR | -112.822% |
| Lasa Supergenerics Limited | 1.5 Billion INR | -157.614% |
| Sun Pharma Advanced Research Company Limited | 5.15 Billion INR | 24.538% |